ShareValue scores for INCR: Valuation 56, Quality 52, Growth 36, Health 47.

InterCure Ltd. logo

INCR
NASDAQ

InterCure Ltd.

$0.93(-2.77%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
56
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
36
Weak
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
43
Neutral
Price Trend

Company Details

About

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026